Delivery Order SPE2DB20D3103-SPE2DB25FP4D3

Award Date 7/7/25
Potential Completion Date 7/28/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract has a ceiling value of $11,830.00 and a completion date of July 31, 2025. It is a firm fixed-price contract, indicating the price is set and will not change. This contract is not a set-aside, meaning it was openly...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $12,604.63 and a performance period through May 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract has a ceiling value of $11,830.00 and is a firm fixed price delivery order. The place of performance is Conshohocken, Pennsylvania. This contract is not set aside for any specific business type....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a medication, with a ceiling value of $11,830.00 and a performance period ending on July 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $11,827.51, is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price arrangement with a period of performance through November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product. The contract has a ceiling value of $11,830.00 and is a firm fixed price delivery order with a period of performance through July 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. The contract has a firm fixed price, with a ceiling value of $18,395.93, and runs through March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,604.63 firm fixed-price contract is for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a specialty medication. The award has an ultimate completion date of April 28, 2025 and is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML medication. The contract has a firm fixed price of $11,827.51 and a period of performance that runs through August 20, 2024. This contract is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,604.63 firm fixed-price contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product, with a period of performance through April 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FP4D3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML, a pharmaceutical product, with a ceiling value of $11,830.00. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 10/12/25, 1:04 AM